Go Back
HOOKIPA Pharma Inc. reports $19.7 million Q1 loss
By USInMinutes - May 11, 2023, 10:22 AM ET
Last Updated - Jul 18, 2023, 03:31 PM EDT
The company generated $3.20 million in quarterly revenue
HOOKIPA Pharma Inc. [HOOK] has reported fiscal Q1 loss of $19.70 million.
On a per-share basis, the DE based company said its diluted earnings are $0.27.
The Pharmaceutical Preparations firm posted revenue of $3.20 million in this period.
Also Read:
- HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
- HOOKIPA Announces First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration ...
- HOOKIPA Pharma to Report First Quarter 2023 Financial Results and Recent Business Highlights on ...
- HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial ...
- HOOKIPA Pharma to Participate in the Van Lanschot Kempen Life Sciences Conference
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News